mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000
View company profile
Please contact the Account Manager for opportunities with this organisation

Lilly delivers "strong operational performance" in 2009

Posted on 01/02/2010 in Pharmaceutical Company Financials

Lilly has posted its financial results for 2009, revealing a strong performance for the period, according to the company's chairman and chief executive officer.

The firm's total revenue reached $5,934 million (3,723 million pounds) during the final quarter of the year, as opposed to $5,204.4 million during the same time in 2008.

This represents growth of 14 per cent, as eight products each exceeded sales of $1 billion for the whole of 2009.

John Lechleiter, chairman and chief executive officer of Lilly, explained that the company's results leave it "well-positioned" to approach 2010.

"In 2009, we delivered solid financial results even as we continued to implement a series of actions aimed at speeding innovation to patients and delivering greater value to our customers," he added.

Earlier this month, Mr Lechleiter emphasised the benefits that medical breakthroughs have for mankind and stated that Lilly's goals within the next decade include focusing upon innovative research and development.

Other news stories from 01/02/2010

Read more in the Zenopa News Archive

How this news is generated

Claire
Account Manager
for this opportunity

01494 818 025
(Mon to Fri 0830 to 1800 hours)
claire@zenopa.com

Latest News

Lilly to receive extension to FDA review of exenatide

Lilly, Pfizer and Merck to collaborate on cancer research

Lilly drug proven to reduce chronic lower back pain

Lilly delivers "strong operational performance" in 2009

Lilly chairman: Medical breakthroughs benefit mankind

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use